相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome
Rachel P. J. Lai et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Diverging biological roles among human monocyte subsets in the context of tuberculosis infection
Luciana Balboa et al.
CLINICAL SCIENCE (2015)
Towards host-directed therapies for tuberculosis
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
The key role of exudative lesions and their encapsulation: lessons learned from the pathology of human pulmonary tuberculosis
Pere-Joan Cardona
FRONTIERS IN MICROBIOLOGY (2015)
Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination
Mardi C. Boer et al.
FRONTIERS IN IMMUNOLOGY (2015)
Inflammation and tuberculosis: host-directed therapies
A. Zumla et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Advancing host-directed therapy for tuberculosis
Robert S. Wallis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Katrin D. Mayer-Barber et al.
NATURE (2014)
In search of a new paradigm for protective immunity to TB
Cludio Nunes-Alves et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Role of Indomethacin in Acute Pain and Inflammation Management:A Review of the Literature
Srinivas Nalamachu et al.
POSTGRADUATE MEDICINE (2014)
Targeting regulatory T cells to improve vaccine immunogenicity in early life
Jorjoh Ndure et al.
FRONTIERS IN MICROBIOLOGY (2014)
Functional signatures of human CD4 and CD8T cell responses to Mycobacterium tuberculosis
Teresa Prezzemolo et al.
FRONTIERS IN IMMUNOLOGY (2014)
PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review
Andrew T. Kunzmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Pathogen-Specific Treg Cells Expand Early during Mycobacterium tuberculosis Infection but Are Later Eliminated in Response to Interleukin-12
Shahin Shafiani et al.
IMMUNITY (2013)
Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
Cristina Vilaplana et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Nonsteroidal Antiinflammatory Drugs for Adjunctive Tuberculosis Treatment
Juraj Ivanyi et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Prominent role for T cell-derived Tumour Necrosis Factor for sustained control of Mycobacterium tuberculosis infection
Nasiema Allie et al.
SCIENTIFIC REPORTS (2013)
Proinflammatory anc immunoregulatory roles of eicosanoids in T cells
Anna Mari Lone et al.
FRONTIERS IN IMMUNOLOGY (2013)
Modulation of T cell immune functions by the prostaglandin E2-cAMP pathway in chronic inflammatory states
Kristoffer Watten Brudvik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14hi/CD16neg monocytes: Expansion of CD14hi/CD16pos and contraction of CD14lo/CD16pos monocytes in acute liver failure
(Robin) Daniel Abeles et al.
CYTOMETRY PART A (2012)
Immunity to TB and targets for immunotherapy
Mercedes Gonzalez-Juarrereo
IMMUNOTHERAPY (2012)
Regulation of Immune Responses by Prostaglandin E-2
Pawel Kalinski
JOURNAL OF IMMUNOLOGY (2012)
New pathways of protective and pathological host defense to mycobacteria
Tom H. M. Ottenhoff
TRENDS IN MICROBIOLOGY (2012)
NF-κB signaling dynamics play a key role in infection control in tuberculosis
Mohammad Fallahi-Sichani et al.
FRONTIERS IN PHYSIOLOGY (2012)
Biology of Cox-2: An Application in Cancer Therapeutics
Zakir Khan et al.
CURRENT DRUG TARGETS (2011)
Human FoxP3+CD4+ regulatory T cells: their knowns and unknowns
Makoto Miyara et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
T Cell-Signaling Network Analysis Reveals Distinct Differences between CD28 and CD2 Costimulation Responses in Various Subsets and in the MAPK Pathway between Resting and Activated Regulatory T Cells
Maria Elisabeth Kalland et al.
JOURNAL OF IMMUNOLOGY (2011)
An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses
Frank O. Pettersen et al.
JOURNAL OF VIROLOGY (2011)
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease
Alexandre Harari et al.
NATURE MEDICINE (2011)
Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins
C. Peres-Buzalaf et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Increased frequency and cell death of CD16+ monocytes with Mycobacterium tuberculosis infection
Diana Castano et al.
TUBERCULOSIS (2011)
Inhibiting NF-kappa B activation by small molecules as a therapeutic strategy
Subash C. Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection
Nadia Caccamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis
Nancy D. Marin et al.
TUBERCULOSIS (2010)
Regulatory T Cells in the Control of Host-Microorganism Interactions
Yasmine Belkaid et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
Eirik A. Torheim et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways
Kushagra Bansal et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
Markus Feuerer et al.
NATURE IMMUNOLOGY (2009)
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
Robert S. Walls
LANCET INFECTIOUS DISEASES (2008)
LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+T cells through a COX-2-PGE2-dependent mechanism
Tone Bryn et al.
INTERNATIONAL IMMUNOLOGY (2008)
CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease
Xinchun Chen et al.
CLINICAL IMMUNOLOGY (2007)
Natural regulatory T cells: mechanisms of suppression
Makoto Miyara et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Inhibitors of NF-κB signaling:: 785 and counting
T. D. Gilmore et al.
ONCOGENE (2006)
Functional and phenotypic changes in monocytes from patients with tuberculosis are reversed with treatment
Maria D. Sanchez et al.
MICROBES AND INFECTION (2006)
FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism
Milada Mahic et al.
JOURNAL OF IMMUNOLOGY (2006)
A combination of a transforming growth factor-β antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis
R Hernández-Pando et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
D Kvale et al.
AIDS (2006)
Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis
V Guyot-Revol et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
F Baratelli et al.
JOURNAL OF IMMUNOLOGY (2005)
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy
CC Johansson et al.
AIDS (2004)
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-κB activation through inhibition of activation of IκBα kinase and Akt in human non-small cell lung carcinoma:: Correlation with suppression of COX-2 synthesis
S Shishodia et al.
JOURNAL OF IMMUNOLOGY (2004)
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults
GE Thwaites et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis
JM Moreno et al.
IMMUNOLOGY (2002)
Therapeutic potential of inhibition of the NF-kappa B pathway in the treatment of inflammation and cancer
Y Yamamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
